Compare IDEXX Laboratories, Inc. (IDXX) vs Direxion Daily S&P 500 Bull 3X Shares (SPXL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Direxion Daily S&P 500 Bull 3X Shares — how do they compare? IDEXX Laboratories, Inc. trades at $551 (market cap $44.48B), while Direxion Daily S&P 500 Bull 3X Shares trades at $271.3. The key difference: Direxion Daily S&P 500 Bull 3X Shares is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| IDXX | SPXL | |
|---|---|---|
Market Cap | $44.48B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $766.68 | $288.04 |
52-Week Low | $520.87 | $170.20 |
Enterprise Value | $45.38B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDXX trades at $563.79, down 0.64% today but maintains strong fundamental momentum with consistent earnings beats and robust profitability. The stock shows bullish technical signals with support at $563 and resistance at $572, while valuation metrics remain elevated. Recent Q1 2026 results exceeded expectations with EPS of $3.47 versus $3.41 estimates, supporting the company's leadership in veterinary diagnostics.
Outlook remains positive given strong analyst support (59% buy ratings) and innovation pipeline, though premium valuations and competitive pressures present risks. Revenue growth trajectory and expanding margins provide fundamental support for continued upside potential in the pet healthcare sector.
SPXL, a leveraged ETF tracking the S&P 500, trades at $264.57, down 0.44% on the day amid broader market weakness. Technical indicators signal a bearish bias with moving averages pointing lower, though oscillators remain neutral. Recent news highlights concerns about S&P 500 valuation and AI-driven concentration risks, with the index facing pressure from chip stock declines and macroeconomic uncertainty.
The outlook hinges on S&P 500 performance, with earnings season and economic data as key catalysts. Risks include market overvaluation and sector concentration, but analyst targets suggest potential upside if bullish forecasts materialize. Investors must weigh leveraged exposure against volatility and broader index trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Direxion Daily S&P 500 Bull 3X Shares
SPXL aims for 300% of the S&P 500's daily performance. It uses swaps and futures to provide 3x leverage, making it a high-risk tool for short-term traders. Due to daily resets, it is prone to volatility decay and is not intended for long-term holding.
Read more on SPXL →
